Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable 1-deoxy-D-xylulose 5-phosphate reductoisomerase Dxr (DXP reductoisomerase) (1-deoxyxylulose-5-phosphate reductoisomeras | 0.0659 | 0.0849 | 1 |
Plasmodium falciparum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.4753 | 0.5 |
Mycobacterium ulcerans | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.4753 | 1 |
Chlamydia trachomatis | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.4753 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.4753 | 0.5 |
Treponema pallidum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.4753 | 0.5 |
Plasmodium vivax | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.1351 | 0.4753 | 0.5 |
Mycobacterium leprae | PROBABLE 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE DXR (DXP REDUCTOISOMERASE) (1-DEOXYXYLULOSE-5-PHOSPHATE REDUCTOISOMERAS | 0.1351 | 0.4753 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 13.6 nM kg-1 | Ability to antagonize paraoxon (1.0 mg/kg sc)-induced motor incoordination in mice. | ChEMBL. | 2033583 |
IC50 (binding) | = 0.05 uM | Concentration required to inhibit hydrolytic activity of bovine erythrocyte acetylcholinesterase by 50% | ChEMBL. | 2033583 |
PD50 (functional) | = 0.66 uM kg-1 | Ability to antagonize paraoxon-induced lethality in mice.(micromol/kg required to protect 50% of the mice for 24 h versus a LD99 dose of paraoxon) | ChEMBL. | 2033583 |
Relative potency (functional) | = 0.21 | The relative potency of the compound was evaluated | ChEMBL. | 2033583 |
Therapeutic index (functional) | = 16 | Compound was evaluated for therapeutic index (LD50 / ED50), in mice | ChEMBL. | 2033583 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.